{"id":9126,"date":"2025-07-01T02:04:00","date_gmt":"2025-07-01T02:04:00","guid":{"rendered":"https:\/\/cdafound.org\/?p=9126"},"modified":"2026-05-29T03:37:51","modified_gmt":"2026-05-29T03:37:51","slug":"modeling-the-health-and-economic-impact-of-pharmacologic-therapies-for-masld-in-the-united-states","status":"publish","type":"post","link":"https:\/\/cdafound.org\/es\/modeling-the-health-and-economic-impact-of-pharmacologic-therapies-for-masld-in-the-united-states\/","title":{"rendered":"Modelizaci\u00f3n del impacto sanitario y econ\u00f3mico de las terapias farmacol\u00f3gicas para la MASLD en los Estados Unidos"},"content":{"rendered":"<h2 class=\"wp-block-heading\" id=\"summary\">Resumen<\/h2>\n\n\n\n<p>La esteatosis hep\u00e1tica asociada a la disfunci\u00f3n metab\u00f3lica (EHAM), la causa m\u00e1s frecuente y de mayor crecimiento de la enfermedad hep\u00e1tica cr\u00f3nica, conlleva costes sanitarios sustanciales. Ante el aumento de la carga de la enfermedad y de los costes, se est\u00e1n desarrollando terapias farmacol\u00f3gicas que detienen la progresi\u00f3n de la fibrosis en la EHAM. La modelizaci\u00f3n del impacto en la progresi\u00f3n de la enfermedad de una terapia farmacol\u00f3gica hipot\u00e9tica que detiene la fibrosis en la EHAM, a trav\u00e9s de diversos escenarios, proporciona informaci\u00f3n valiosa sobre los principales factores que impulsan la enfermedad y los costes asociados. Esto deber\u00eda contribuir a la implementaci\u00f3n de las mejores pol\u00edticas y pr\u00e1cticas para mitigar la carga de la EHAM.<\/p>\n\n<div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button is-style-outline is-style-outline--1\"><a class=\"wp-block-button__link has-text-color wp-element-button\" href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2026\/05\/Wallace-2025-MASH-treatment-impact-US.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Lea el informe completo<\/a><\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Summary Metabolic dysfunction-associated steatotic liver disease (MASLD), the most rapidly increasing and prevalent cause of chronic liver disease, is associated with substantial healthcare costs. As disease burden and costs mount, pharmacologic therapy which halts MASLD fibrosis progression is coming to fruition. Modeling the impact on disease progression of a hypothetical pharmacologic therapy which halts MASLD [&hellip;]<\/p>\n","protected":false},"author":939,"featured_media":5127,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[9],"tags":[32,2688,12],"publication-author":[2676,2675,95,97,92],"class_list":["post-9126","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-publication","tag-economic-impact","tag-masld","tag-modelling","publication-author-arun-j-sanyal","publication-author-carolyn-wallace","publication-author-chris-estes","publication-author-homie-razavi","publication-author-ivane-gamkrelidze"],"acf":[],"_links":{"self":[{"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/posts\/9126","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/users\/939"}],"replies":[{"embeddable":true,"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/comments?post=9126"}],"version-history":[{"count":2,"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/posts\/9126\/revisions"}],"predecessor-version":[{"id":9129,"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/posts\/9126\/revisions\/9129"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/media\/5127"}],"wp:attachment":[{"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/media?parent=9126"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/categories?post=9126"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/tags?post=9126"},{"taxonomy":"publication-author","embeddable":true,"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/publication-author?post=9126"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}